Literature DB >> 14684410

Dose response of bone mass to dietary arachidonic acid in piglets fed cow milk-based formula.

Janice L Blanaru1, June R Kohut, Shirley C Fitzpatrick-Wong, Hope A Weiler.   

Abstract

BACKGROUND: The addition of arachidonic acid (AA) and docosahexaenoic acid (DHA) to infant formula was recently approved in North America. In piglets, dietary AA is linked to elevations in bone mass.
OBJECTIVE: The objective was to investigate the effects of varied amounts of dietary AA on bone modeling and bone mass with the use of the piglet model for infant nutrition.
DESIGN: Male piglets (n = 32) were randomly assigned to receive 1 of 4 formulas supplemented with AA (0.30%, 0.45%, 0.60%, or 0.75% of fat) plus DHA (0.1% of fat) from days 5 to 20 of life. Measurements included biomarkers of bone modeling, fatty acid status, and whole-body and femur bone mineral content; bone area was measured by dual-energy X-ray absorptiometry. Differences among groups were detected with two-factor analysis of variance. Regression analyses were used to determine factors responsible for bone mineral content after dietary AA was accounted for.
RESULTS: Proportions of AA in plasma, liver, and adipose were modified by the dietary treatments, but bone modeling was not affected. Liver AA was positively related to plasma insulin-like growth factor 1 and calcitriol and urinary N-telopeptide. Whole-body bone mineral content was elevated in the piglets fed 0.60% and 0.75% AA and was best predicted by dietary AA and bone resorption.
CONCLUSIONS: This study confirms that dietary AA alters bone mass and clarifies the best amount of AA to add to the diet of pigs born at term. Because the amount of dietary DHA was held constant, whether other amounts of DHA are related to bone mass requires investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14684410     DOI: 10.1093/ajcn/79.1.139

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  6 in total

1.  Evaluation of bioequivalency and toxicological effects of three sources of arachidonic acid (ARA) in domestic piglets.

Authors:  Cynthia Tyburczy; Margaret E Brenna; Joseph A DeMari; Kumar S D Kothapalli; Bryant S Blank; Helen Valentine; Sean P McDonough; Dattatreya Banavara; Deborah A Diersen-Schade; J Thomas Brenna
Journal:  Food Chem Toxicol       Date:  2011-06-21       Impact factor: 6.023

2.  Plasma phosphatidylcholine concentrations of polyunsaturated fatty acids are differentially associated with hip bone mineral density and hip fracture in older adults: the Framingham Osteoporosis Study.

Authors:  Emily K Farina; Douglas P Kiel; Ronenn Roubenoff; Ernst J Schaefer; L Adrienne Cupples; Katherine L Tucker
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

3.  Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study.

Authors:  Emily K Farina; Douglas P Kiel; Ronenn Roubenoff; Ernst J Schaefer; L Adrienne Cupples; Katherine L Tucker
Journal:  Am J Clin Nutr       Date:  2011-03-02       Impact factor: 7.045

4.  Dietary intakes of arachidonic acid and alpha-linolenic acid are associated with reduced risk of hip fracture in older adults.

Authors:  Emily K Farina; Douglas P Kiel; Ronenn Roubenoff; Ernst J Schaefer; L Adrienne Cupples; Katherine L Tucker
Journal:  J Nutr       Date:  2011-04-20       Impact factor: 4.798

5.  Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice.

Authors:  Sasanka Ramanadham; Kevin E Yarasheski; Matthew J Silva; Mary Wohltmann; Deborah Veis Novack; Blaine Christiansen; Xiaolin Tu; Sheng Zhang; Xiaoyong Lei; John Turk
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 6.  The Essentiality of Arachidonic Acid in Infant Development.

Authors:  Kevin B Hadley; Alan S Ryan; Stewart Forsyth; Sheila Gautier; Norman Salem
Journal:  Nutrients       Date:  2016-04-12       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.